Philips
RELATED CONTENT
Royal Philips Electronics showcased its latest addition to the ClearVue ultrasound family of products at the American College of Obstetricians and Gynecologists 61st Annual Clinical Meeting in New Orleans May 4-8, 2013. The ClearVue 650 is a lightweight and cost-effective system that spans a range of applications from obstetrics and gynecology to cardiology, abdominal, vascular, breast, musculoskeletal, urology and general imaging.
May 08, 2013 
The Focused Ultrasound Foundation, Royal Philips Electronics and InSightec Ltd today announced that they are collaborating with leading clinicians in the field and support the establishment of a multicenter registry to evaluate MR-guided focused ultrasound treatment for uterine fibroids (also known as uterine leiomyomas).
May 08, 2013 
Imaging children has challenges that relate to the size, maturity and anxiety of the patient. In addition, we have become increasingly aware of the risks associated with radiation exposure, an issue that is of paramount importance to young patients. Through the efforts of professional organizations, industry and the Image Gently campaign, launched in 2008 by The Alliance for Radiation Safety in Pediatric Imaging, tremendous advancements have been made in technology and its use to help meet these challenges.
April 26, 2013 
New computed tomography (CT) dose studies and growing public media attention have made minimizing unnecessary radiation dose to patients a priority for medical imaging facilities. In addition, state regulatory agencies and accrediting bodies are increasing their oversight and regulation of radiation dose. Reducing dose while maintaining good clinical image quality, however, is complex.
April 26, 2013 At the International Society for Magnetic Resonance in Medicine’s (ISMRM) 21st Annual Meeting in Salt Lake City, Utah, Philips Healthcare demonstrated a range of clinical functionalities in magnetic resonance imaging (MRI).
April 25, 2013 
When every second counts in clinical situations such as those encountered in the emergency room and trauma centers, fast high-resolution CT scanning at low radiation dose helps radiologists render quick, confident diagnoses while keeping in mind the patient's needs. Delivering speed and performance, Philips iDose4 generates results in seconds rather than minutes, with a majority of reference protocols reconstructed in 60 seconds or less. Moreover, the Metal Artifact Reduction for large Orthopedic Implants (O-MAR) reconstruction technology reduces artifacts from metal objects, thus reducing the potential loss of critical anatomical information.
Philips has taken CT scanning to a whole new level by developing medical imaging technologies that combine fast reconstruction, high image quality and low radiation dose. This advancement was brought about by Philips collaborating with Intel to enhance its imaging software to take advantage of state-of-the-art, massively-parallel computing platforms based on Intel Xeon processors.
This paper details the high performance derived from Philips reconstruction technologies: Philips iDose4 and O-MAR. Some of the software optimization techniques used by Philips engineers are also described. As a next step in transforming care, Philips has launched the next innovation, called IMR. IMR is a model-based iterative reconstruction, which will run on even more powerful Intel processors and pave the way for further advances in CT imaging.
April 05, 2013 Royal Philips Electronics is introducing three new imaging systems to help radiology departments increase both the number of patients and range of clinical exams they can handle. Showcased at the 2013 European Congress of Radiology (ECR 2013), all three systems combine the capabilities for high patient throughput with the functionality and advanced clinical imaging applications.
April 01, 2013 
Advances in digital mammography are evolving as clinicians look to improve breast cancer screening in women. In recent years, new technological trends have emerged; notably, the addition of 3-D breast imaging, or tomosynthesis, which was approved by the U.S. Food and Drug Administration (FDA) in 2011. But as technology improves, questions remain over the recommended frequency of screening for breast cancer.
March 19, 2013 
Increasing research on women with dense breasts is having a positive effect on imaging modalities. It is estimated that between 30–40 percent of women in the United States have dense breasts. Because fatty breast tissue makes it difficult to identify breast tumors on standard mammography exams until very advanced stages, dense breasts are a strong independent factor for breast cancer. Research has shown that it is beneficial for this population of women to invest in additional imaging.
March 19, 2013 
Royal Philips Electronics announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroDose SI system, the first full-field digital mammography (FFDM) system on the market with the capability to enable future Single-Shot Spectral Imaging applications*. Philips is working on future software applications like Spectral Breast Density Measurement*, which will build upon the MicroDose SI technology.
March 05, 2013